A multidisciplinary team of health care professionals, including pharmacists, can work together to treat patients with the bleeding disorder.
Gina Dube, PharmD, RPh, CACP
Advertisement
Articles by Gina Dube, PharmD, RPh, CACP
Additional randomized clinical trials are warranted to determine the mechanism between the 2 diseases.
Antiphospholipid Antibody Syndrome may be associated with an increased risk of venous thromboembolism complications in severe cases.
Conduct proper review and evaluation of ARV and DOAC pharmacokinetics and metabolism prior to recommending treatment.
Significant morbidity and mortality are associated with an aging population due to cardiovascular disease, which is very common in HIV-infected persons.
Advertisement
Latest Updated Articles
Antiretroviral Therapy, Anticoagulants in HIV-infected Patients for Stroke Prevention in Atrial FibrillationPublished: July 14th 2020 | Updated:
Anticoagulants, Antiretrovirals Can Prevent Strokes in AF for Patients With HIVPublished: September 30th 2020 | Updated:
COVID-19 Is Linked to Cardiovascular ComplicationsPublished: November 17th 2020 | Updated:
COVID-19 and Diabetes: Is There a Connection?Published: January 28th 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Grants Interchangeability Designation to Denosumab Biosimilars Stoboclo and Osenvelt
2
Because Ned Said: America’s Growing Pharmacy Deserts Are Leaving Patients High and Dry
3
Meeting Patients Where They Are: How Pharmacists Are Helping People Stay on Track With Schizophrenia Treatment
4
Incidence of Invasive Fungal Infections Following BCMA-Directed CAR T-Cell Therapy in Multiple Myeloma
5
